NVS Total Non-Current Assets

Novartis AG Common Stock · Total Non-Current Assets

NVS logo

NVS Total Non-Current Assets

Latest reported$94.68B
NVS Quarterly Non-Current Assets ($15.52B → $94.68B)
High-resolution chart · PNG

NVS total non-current assets history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Novartis AG Common Stock Total Non-Current Assets — Quarterly (USD)
Period endingTotal Non-Current Assets (USD)
94,682,379,000
91,925,000,000
85,109,146,000
79,091,000,000
78,456,000,000
74,833,000,000
72,542,000,000
72,260,000,000
71,812,000,000
67,887,000,000
73,342,855,587
67,037,000,000
77,486,000,000
80,127,000,000
84,855,205,349
81,510,000,000
84,768,000,000
87,982,000,000
90,166,000,000
94,956,000,000
100,207,000,000
99,554,000,000
102,516,000,000
100,705,000,000
99,881,000,000
99,999,000,000
88,908,615,735
89,296,000,000
87,974,000,000
85,498,000,000
110,000,000,000
108,881,000,000
109,993,000,000
102,473,000,000
104,871,000,000
107,506,000,000
107,211,000,000
106,220,000,000
105,193,000,000
108,124,000,000
107,714,000,000
109,455,000,000
108,711,000,000
108,882,000,000
110,667,000,000
109,225,000,000
87,826,000,000
88,589,000,000
90,795,000,000
95,644,000,000
95,712,000,000
95,824,000,000
94,227,000,000
94,216,000,000
96,212,000,000
95,071,000,000
92,370,000,000
93,624,000,000
93,412,000,000
95,814,000,000
99,286,000,000
98,118,000,000
96,633,000,000
96,912,000,000
58,257,000,000
59,995,000,000
61,814,000,000
60,246,000,000
57,102,000,000
55,488,000,000
57,418,000,000
58,723,000,000
51,314,000,000
50,031,000,000
48,022,000,000
48,254,000,000
49,984,000,000
46,990,000,000
46,604,000,000
45,889,000,000
46,134,000,000
36,933,000,000
36,289,000,000
36,194,000,000
32,929,000,000
27,383,000,000
29,858,000,000
27,982,000,000
27,005,000,000
27,059,000,000
27,044,000,000
25,814,000,000
25,475,000,000
24,782,000,000
24,274,000,000
22,992,000,000
22,322,000,000
19,665,000,000
18,855,000,000
15,400,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.